Miosite de corpos de inclusão: Série de 30 casos de um centro terciário brasileiro

Acta Reumatologica Portuguesa

Volumn 38, Issue 3, 2013, Pages 179-185

  Mont' Alverne, Andrea Rocha de Saboia ^a   Marie, Suely Kazue Nagahashi ^a   Levy Neto, Maurício ^a   de Souza, Fernando Henrique Carlos ^a   de Carvalho, Mary Souza ^a   Shinjo, Samuel Katsuyuki ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Epidemiology; Inclusion body myositis; Inflammatory myopathy

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; FEMALE; HUMAN; INCLUSION BODY MYOSITIS; MALE; MIDDLE AGED; TERTIARY CARE CENTER;

ADULT; AGED; BRAZIL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; TERTIARY CARE CENTERS;

EID: 84886631904     PISSN: 0303464X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Yunis EJ, Samaha FJ. Inclusion body myositis. Lab Invest 1971; 25: 240-248.
2. Phillips BA, Zilko PJ, Mataglia FL. Prevalence of sporadic inclusion body myositis in Western Australia. Muscle Nerve 2000; 23: 970-972.
3. Badrising UA, Maat-Schieman M, van Duinen SG et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000; 55: 1385-1387.
4. Wilson FC, Ytterberg SR, St Sauver JL, Reed AM. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol 2008; 35: 445-447.
5. Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia FL. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. J Clin Neurosci 2008; 15: 1350-1353.
6. Machado P, Miller A, Holton J, Hanna M. Sporadic inclusion body myositis: an unsolved mystery. Acta Reumatol Port 2009; 34:161-182.
7. Mastaglia FL. Sporadic inclusion body myositis: variability in prevalence and phenotype and influence of the MHC. Acta Myol 2009; 28: 66-71.
8. Amato AA, Gronseth GS, Jackson CE et al. Inclusion body myositis: clinical and pathologic boundaries. Ann Neurol 1996; 40: 581-586.
9. Lotz B, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis: observations in 40 patients. Brain 1989; 112: 727-747.
10. Felice KJ, North WA. Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine 2001; 80: 320-327.
11. Griggs RC, Askanas V, DiMauro S et al. Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705-713.
12. Hanissian AS, Masi AT, Pitner SE, Cape CC, Medsger TA Jr. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol 1982; 9: 390-394.
13. Scola RH, Werneck LC, Franco CR. Cytoplasmic inclusion bodies: a study in several diseases and a review of the literature. Arq Neuropsiquiatr 1996; 54: 245-259.
14. Sayers ME, Chou SM, Calabrese LH. Inclusion body myositis: analysis of 32 cases. J Rheumatol 1992; 19: 1385-1389.
15. Beyenburg S, Zierz S, Jerusalem F. Inclusion body myositis: clinical and histopathological features of 36 patients. Clin Investig 1993; 71: 351-361.
16. Felice KJ, North WA. Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine 2001; 80: 320-327.
17. Benveniste O, Guiguet M, Freebody J et al. Long-term observational study of sporadic inclusion body myositis. Brain 2011; 134(Pt 11): 3176-3184.
18. Lindberg C, Persson LI, Bjorkander J, Oldfors A. Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases. Acta Neurol Scand 1994; 89: 123-131.
19. Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA. A 12-year follow-up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011; 134: 3167-3175.
20. Badrising UA, Maat-Schieman ML, van Houwelingen JC et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 2005; 252: 1448-1454.
21. Needham M, Mastaglia FL. Inclusion body myositis: current pathogenetic concepts and diagnostic and therapeutic approaches. Lancet Neurol 2007; 6: 620-631.
22. Needham M, James I, Corbett A et al. Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 2008; 79: 1056-1060.
23. Cox FM, Delgado V, Verschuuren JJ et al. The heart in sporadic inclusion body myositis: a study in 51 patients. J Neurol 2010; 257: 447-451.
24. Alexandrescu DT, Bhagwati NS, Fomberstein B, Wolfe DE, Feliz A, Wiernik PH. Steroid-responsive inclusion body myositis associated with endometrial cancer. Clin Exp Rheumatol 2005; 23: 93-96.
25. Jensen ML, Wieting JM, Andary MT, Fankhauser MJ, Jones MJ. Inclusion body myositis and transitional cell carcinoma of the bladder: significant resolution of symptoms after tumor excision. Arch Phys Med Rehabil 1997; 78: 327-329.
26. Buchbinder R, Forbes A, Hall S, Dennett X, Giles G. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-1095.
27. Tsuruta Y, Yamada T, Yoshimura T et al. Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi 2001; 92: 370-376.
28. Warabi Y, Matsubara S, Mizutani T, Hayashi H. [Inclusion body myositis after interferon-alpha treatment in a patient with HCV and HTLV-1 infection]. Rinsho Shinkeigaku 2004; 44: 609-614.
29. Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC. Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain 1996; 119: 1887-1893.
30. Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral therapy (HAART). Muscle Nerve 2005; 32: 247-260.
31. Rifai Z, Welle S, Kamp C, Thornton CA. Ragged red fibers in normal aging and inflammatory myopathy. Ann Neurol 1995; 37: 24-29.
32. Tritschler HJ, Medori R. Mitochondrial DNA alterations as a source of human disorders. Neurology 1993; 43: 280-288.
33. Oldfors A, Larsson NG, Lindberg C, Holme E. Mitochondrial DNA deletions in inclusion body myositis. Brain 1993; 116: 325-336.
34. Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. J Neuropathol Exp Neurol 1995; 54: 581-587.
35. Schroder JM, Molnar M. Mitochondrial abnormalities and peripheral neuropathy in inflammatory myopathy, especially inclusion body myositis. Mol Cell Biochem 1997; 174: 277-281.
36. Cote HC, Brumme ZL, Craib KJ et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002; 346: 811-820.